Taiwan · Delayed Price · Currency is TWD TaiMed Biologics Statistics
Total Valuation
TPEX:4147 has a market cap or net worth of TWD 17.24 billion. The enterprise value is 16.08 billion.
| Market Cap | 17.24B |
| Enterprise Value | 16.08B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4147 has 273.20 million shares outstanding. The number of shares has decreased by -1.18% in one year.
| Current Share Class | 273.20M |
| Shares Outstanding | 273.20M |
| Shares Change (YoY) | -1.18% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 5.34% |
| Float | 182.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.83 |
| PB Ratio | 4.69 |
| P/TBV Ratio | 5.25 |
| P/FCF Ratio | 159.61 |
| P/OCF Ratio | 111.14 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 148.90 |
Financial Position
The company has a current ratio of 15.48, with a Debt / Equity ratio of 0.12.
| Current Ratio | 15.48 |
| Quick Ratio | 8.47 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.17 |
| Interest Coverage | -18.03 |
Financial Efficiency
Return on equity (ROE) is -3.66% and return on invested capital (ROIC) is -2.74%.
| Return on Equity (ROE) | -3.66% |
| Return on Assets (ROA) | -2.52% |
| Return on Invested Capital (ROIC) | -2.74% |
| Return on Capital Employed (ROCE) | -4.36% |
| Weighted Average Cost of Capital (WACC) | 3.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.58% in the last 52 weeks. The beta is -0.16, so TPEX:4147's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -21.58% |
| 50-Day Moving Average | 61.26 |
| 200-Day Moving Average | 58.84 |
| Relative Strength Index (RSI) | 52.85 |
| Average Volume (20 Days) | 1,164,976 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4147 had revenue of TWD 619.49 million and -138.90 million in losses. Loss per share was -0.51.
| Revenue | 619.49M |
| Gross Profit | 266.85M |
| Operating Income | -187.53M |
| Pretax Income | -138.90M |
| Net Income | -138.90M |
| EBITDA | -39.10M |
| EBIT | -187.53M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 1.61 billion in cash and 450.00 million in debt, with a net cash position of 1.16 billion or 4.24 per share.
| Cash & Cash Equivalents | 1.61B |
| Total Debt | 450.00M |
| Net Cash | 1.16B |
| Net Cash Per Share | 4.24 |
| Equity (Book Value) | 3.68B |
| Book Value Per Share | 13.65 |
| Working Capital | 2.86B |
Cash Flow
In the last 12 months, operating cash flow was 155.12 million and capital expenditures -47.11 million, giving a free cash flow of 108.01 million.
| Operating Cash Flow | 155.12M |
| Capital Expenditures | -47.11M |
| Depreciation & Amortization | 148.43M |
| Net Borrowing | -29.81M |
| Free Cash Flow | 108.01M |
| FCF Per Share | 0.40 |
Margins
Gross margin is 43.08%, with operating and profit margins of -30.27% and -22.42%.
| Gross Margin | 43.08% |
| Operating Margin | -30.27% |
| Pretax Margin | -22.42% |
| Profit Margin | -22.42% |
| EBITDA Margin | -6.31% |
| EBIT Margin | -30.27% |
| FCF Margin | 17.43% |
Dividends & Yields
TPEX:4147 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.18% |
| Shareholder Yield | 1.18% |
| Earnings Yield | -0.81% |
| FCF Yield | 0.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |